Kantrowitz
Adrian Kantrowitz, Auburn Hills, MI US
Patent application number | Description | Published |
---|---|---|
20080281412 | RIGID BODY AORTIC BLOOD PUMP IMPLANT - An implantable aortic blood pump includes a rigid body having wall extending along a long axis and defining an inflation port portion with an inflation aperture therethrough. The aperture is fluid communication with an inner surface of the body and on a fluid supply, the body is preferably independent of an external brace or an external stiffener, yet still has a cantilevered deformation of less than 8 millimeters in response to a 200 gram weight suspended from a front body edge. A deflecting structure of a membrane deflects in response to fluid pressure so as to pump blood when the pump is secured to a subject aorta. | 11-13-2008 |
20140088340 | STABLE AORTIC BLOOD PUMP IMPLANT - An aortic blood pump is described that is secured to a patient aorta that can be inflated and deflated in response to selective communication with a source of pressurized fluid or air. An expanded stent creates an area in with the pump and inflate and deflate. A system is also detailed including the pump and an external air line external to a patient body. | 03-27-2014 |
Adrian Kantrowitz, Detroit, MI US
Patent application number | Description | Published |
---|---|---|
20140364680 | RIGID BODY AORTIC BLOOD PUMP IMPLANT - An implantable aortic blood pump includes a rigid body having wall extending along a long axis and defining an inflation port portion with an inflation aperture therethrough. The aperture is fluid communication with an inner surface of the body and on a fluid supply, the body is preferably independent of an external brace or an external stiffener, yet still has a cantilevered deformation of less than 8 millimeters in response to a 200 gram weight suspended from a front body edge. A deflecting structure of a membrane deflects in response to fluid pressure so as to pump blood when the pump is secured to a subject aorta. | 12-11-2014 |
Allen B. Kantrowitz, Williamstown, MA US
Patent application number | Description | Published |
---|---|---|
20080281147 | Long term ambulatory intro-aortic balloon pump with percutaneous access device - Disclosed herein are embodiments of long-term ambulatory intra-aortic balloon pump systems for providing left ventricular cardiac assistance to a patient. The systems can comprise an external drive system for supplying a compressed fluid, the drive system operating in accordance with a control program stored in memory, an intra-luminal balloon pump having an elongate inflatable chamber positionable to be lying completely within a descending aorta of the patient, and a percutaneous access device. The percutaneous access device can be a biocompatible implantable portal comprising a communicative passage through an interior bore and an exterior having a neck region adapted to promote autologous cell growth thereon in an implantable region, the neck region having a plurality of channels extending about the neck region. | 11-13-2008 |
20080281412 | RIGID BODY AORTIC BLOOD PUMP IMPLANT - An implantable aortic blood pump includes a rigid body having wall extending along a long axis and defining an inflation port portion with an inflation aperture therethrough. The aperture is fluid communication with an inner surface of the body and on a fluid supply, the body is preferably independent of an external brace or an external stiffener, yet still has a cantilevered deformation of less than 8 millimeters in response to a 200 gram weight suspended from a front body edge. A deflecting structure of a membrane deflects in response to fluid pressure so as to pump blood when the pump is secured to a subject aorta. | 11-13-2008 |
20090131741 | Methods of making aortic counter pulsation cardiac assist devices with three dimensional tortuous shape - Disclosed herein are methods of making aortic counter pulsation cardiac assist devices for assisting cardiac function of a patient. The methods can comprise performing at least one medical imaging procedure on an aorta of the patient, selecting at least one active segment of the aortic counter pulsation cardiac assist device based on anatomic information resulting from the at least one medical imaging procedure, and assembling the at least one active segment to accommodate the anatomic information prior to surgical implantation. The methods can further comprise designing individual custom active segment modules to custom fit a patient, providing a series of different individual, pre-manufactured active segment modules that are assembled to custom fit the patient, or providing a range of stock segment configurations manufactured based on previously determined common configurations and selecting one for a particular patient. | 05-21-2009 |
20090294531 | CONTAINERIZED INVENTORY MANAGEMENT SYSTEM UTILIZING IDENTIFICATION TAGS - An inventory control process includes the association of an inventory item with a reusable container at an origination point. The container is inclusive of a passive or active identification tag. The container is transported within the range of a transponder able to share information with the identification tag. Upon reaching a destination point, the inventory item is unpacked from the container and the container recycled for association with a new inventory item. An inventory delivery device includes a reusable container labeled with an active identification tag. An inventory item is inserted within the container. A disposable tamper-evident seal retaining the inventory item with the container is provided. The device is particularly well suited for transportation for timely and high clinical value items within a medical care setting. | 12-03-2009 |
20100143577 | PERCUTANEOUS ACCESS DEVICE SYSTEM FACILITATING CELL GROWTH THEREON - A biocompatible implantable portal is provided that has a wall defining a communicative passage through an interior bore. The exterior of the portal has a neck region adapted to promote autologous cell growth on the neck region. A series of channels are provided on the exterior neck region to facilitate autologous cell growth while disfavoring fluid pooling and bacterial growth. Typical channel widths are from 20 to 300 microns, with adjacent channels being separated by plateaus having a width of between 0 and 600 microns. Providing the portal exterior neck region with a texture varying on a nanometer length scale facilitates autologous cell growth. Applying a coating such as a tissue scaffolding matrix to the neck region prior to implantation also facilitates cell growth. A coupling or a manifold encompassing the neck region facilitates the draw of vacuum and/or mechanical protection for the growing cells. | 06-10-2010 |
20120150149 | PERCUTANEOUS ACCESS DEVICE SYSTEM FACILITATING CELL GROWTH THEREON - A process to facilitate growing of cells on a nanotextured percutaneous portal is provided that includes the placement of a nanotextured percutaneous portal partially within a subject. A vacuum manifold is secured to the nanotextured percutaneous portal. Upon coupling the vacuum manifold to a vacuum source, the growth of the cells is facilitated. | 06-14-2012 |
Allen B. Kantrowitz, Miami Beach, FL US
Patent application number | Description | Published |
---|---|---|
20120137402 | SURGICAL GLOVE APPLIANCE DEVICE - A protective barrier, such as a medical examination glove is provided that includes a bracelet defining a plane with a cylinder attached to the bracelet at a first end. The cylinder is compressed into a compressed conformation in the plane without rolling about the bracelet. When the barrier is a glove, three fenestrated caps are provided, each such cap attached to the cylinder at different locations along the length of the cylinder when said first cylinder is in an extended conformation. Multiple finger cylinders are each attached to the cylinder at a location of a fenestrated cap, the finger cylinders each having an end cap. The first cylinder and the finger cylinders each compressed into a compressed conformation in the plane such that each of the caps forms a portion of the surface of the plane. | 06-07-2012 |
20120310181 | VACUUM ASSISTED PERCUTANEOUS APPLIANCE - A device for reducing agent penetration at an insertion site is provided that has a porous inner sleeve fluidly connected to a conduit. A vacuum or hydrodynamic source is fluidly connected to the conduit. The device is stabilized by fibroblast in-growth and inhibits bacterial colonization. A device is also provided that has a conduit having a bore and an outer conduit surface. The outer conduit surface is optionally nanotextured to promote fibroblast adhesion and limit bacterial residency. A sleeve is provided in fluid communication with the bore of the conduit, and is formed from materials characterized by a pore matrix through which vacuum or hydrodynamic draw is achieved in a process to promote stabilization and reducing bacterial colonization by draw fluid from an area around the surrounding the site of the device. The sleeve optionally has a distal nanotextured surface. | 12-06-2012 |
20130104284 | INFECTION CONTROL GLOVE WITH SENSORY CONTAMINATION INDICATOR | 05-02-2013 |
Allen B. Kantrowitz, Miami, FL US
Patent application number | Description | Published |
---|---|---|
20130006186 | VACUUM ASSISTED PERCUTANEOUS APPLIANCE - A device for reducing agent penetration at an insertion site is provided that has a porous inner sleeve fluidly connected to a conduit. A vacuum or hydrodynamic source is fluidly connected to the conduit. The device is stabilized by fibroblast in-growth and inhibits bacterial colonization. | 01-03-2013 |
20130131436 | CARDIAC ASSIST DEVICE, INSTRUMENTS, AND METHODS - A cardiac assist device is provided that can be deployed in any region of the aorta by minimally invasive techniques by the way of an inventive fastener that affixes the device to the aorta wall at the site of an aortonomy. The devices and methods described herein allow for improved patient outcome. | 05-23-2013 |
20130261676 | BONE ANCHOR - A biocompatible implantable bone anchor is provided that has a threaded first portion that engages and anchors into a bone. The implant also has a neck region extending from the first portion adapted to promote autologous cell growth thereon at an interface of the bone and one or more epidermal or gum layers, the neck region having a plurality of channels extending about the neck region. The neck region is configured to mechanically engage at least one of an abutment, dental restoration, or osseous device attachment. An in situ bone anchor cell growth assembly includes the bone anchor and a manifold encompassing the neck portion so as to form a seal therebetween and a route of fluid communication between a manifold inlet and at least one of said plurality of channels. A process for growing autologous cells on a neck region of a bone anchor is provided. | 10-03-2013 |
Allen B. Kantrowitz, Detroit, MI US
Patent application number | Description | Published |
---|---|---|
20140364680 | RIGID BODY AORTIC BLOOD PUMP IMPLANT - An implantable aortic blood pump includes a rigid body having wall extending along a long axis and defining an inflation port portion with an inflation aperture therethrough. The aperture is fluid communication with an inner surface of the body and on a fluid supply, the body is preferably independent of an external brace or an external stiffener, yet still has a cantilevered deformation of less than 8 millimeters in response to a 200 gram weight suspended from a front body edge. A deflecting structure of a membrane deflects in response to fluid pressure so as to pump blood when the pump is secured to a subject aorta. | 12-11-2014 |
Christopher Kantrowitz, Los Angeles, CA US
Patent application number | Description | Published |
---|---|---|
20150249694 | MANAGING DOWNLOADS OF LARGE DATA SETS - In a system for downloading large data sets, when a user downloads a project or other large data set from the file sharing service, the user's computer first determines whether files in the data set are already resident on local storage. Files that are in a locally connected storage device, including network connected storage devices, are copied to the download location specified for the data set to be downloaded. Files that are not in local storage are then downloaded to the download location specified for the data set. Files in local storage are indexed to facilitate matching with files used in the project. Such indexing is based on processing the media data in the media data files to ensure that there is a match. For example, a signature can be generated from a portion of a file, such as a first block of media data from a file. This signature can be added to an index, along with other information about the file, such as metadata from the file, file names or file identifiers and the like. A matching algorithm processes files in the project to be shared, and matches them against the index. | 09-03-2015 |
Evan R. Kantrowitz, Waban, MA US
Patent application number | Description | Published |
---|---|---|
20120028892 | INHIBITORS OF FRUCTOSE 1,6-BISPHOSPHATASE AND METHODS OF USE THEREOF - The invention is directed to a compound according to formula (I). The compounds of formula (I) include prodrugs, pharmaceutically acceptable salts, stereoisomer mixtures, and enantiomers thereof. The invention is also directed to a pharmaceutical composition comprising a compound according to formula (I) and a pharmaceutically acceptable carrier and to methods for treating diabetes by administering such a pharmaceutical composition alone or in combination with other therapeutic agents. The invention is also directed to inhibitors of fructose-1,6-bisphosphatase. | 02-02-2012 |
Mark Kantrowitz, Cranberry Township, PA US
Patent application number | Description | Published |
---|---|---|
20090177491 | Method for Minimizing the Cost of Post-Treatment Follow-Up and Diagnostic Tests - A method for determining an optimized surveillance schedule of follow-up diagnostic tests and doctor visits considers the tradeoff between timely detection of relapse and the cost of the diagnostic procedures. A method for generating a surveillance schedule for monitoring a recurrence of a condition includes the steps of (a) scheduling an initial testing date to test for the recurrence of the condition; (b) establishing a threshold, wherein the threshold is the cost associated with a subsequent testing date over the cost per recurrence detected; and (c) scheduling each subsequent testing date to test for the recurrence of the condition when a cumulative risk of recurrence of the condition since the previous testing date exceeds the threshold. A system utilizing this method is also disclosed. | 07-09-2009 |